Lipopeptides are a particular group of cyclic peptides consisted of biomolecules with either a net negative (e.g., surfactin, daptomycin) or net positive charge (e.g., polymyxin). There are remarkable medicinal and biotechnological properties of these bioactive secondary metabolites (
1-
3). Surfactin is a cyclic amphipathic lipopeptide with a molecular weight of 1036 Da. A cyclic lactone ring arrangement with 12 to 16 carbon atoms shapes this heptapeptide (ELLVDLL) secondary metabolite, with the chiral series LLDLLDL interlinked with the chain lengths of β-hydroxy fatty acid (
Figure 1). The residues of hydrophobic amino acids are found at situations 2, 3, 4, 6, and 7, though the residues of glutamyl and aspartyl at positions 1 and 5, respectively, give two negative charges to the molecule (
4,
5). Surfactin adapts a beta-sheet structure with a distinctive horse-saddle conformation in an aqueous system and at the water/air interface, whose wide range of biological activities likely arises from this type of structure (
6-
8). During the stationary phase, surfactin is synthesized by various
Bacillus species when nutrients are limited in culture media. By using different mutants lacking the synthesis of surfactin, a wide range of studies has been carried out on the role of this lipopeptide in bacterial physiology. In these strains, different functions are affected, such as swarming colonies in solid media (
9,
10). Numerous potential functions have also been suggested: The enhancement of hydrophobic water-insoluble growth substrates in the surface area, resulting in higher bioavailability of nutrients and an effect on the binding and separation of bacterial cells to and from substrates (
11,
12).
Besides its interfacial properties, surfactin exhibits several biological activities: (1) antibacterial and anti-inflammatory, (2) hemolytic, (3) antiviral, (4) anti-mycoplasma, (5) antitumoral, and (6) thrombolytic activities (
13-
16). Surfactin interacts with membranes and initiates lipid phase transitions as well as membrane destabilization (
16). Various studies in the fields of genetics, biophysics, and biochemistry have revealed that phospholipids have numerous functions in different processes in cells. Their fundamental and prominent roles form a phospholipid bilayer as a permeability barrier to cells. This bilayer acts as a matrix and takes care of various proteins that have an essential function in cells, including energy or signal transduction, transport of solutes, DNA replication, targeting and trafficking of proteins, identification of cells, secretion, etc. (
17). In every eukaryotic cell, the difference in head and aliphatic lipid chains leads to approximately 1,000 distinct lipid types (
18,
19). Lipid compositions in prokaryotic and eukaryotic cell membranes are different from each other. Phosphatidic acid (PA), phosphatidylcholine (PtdCho), phosphatidylserine (PtdSer), phosphatidylethanolamine (PtdEtn), and phosphatidylinositol (PtdIns) are the most common structural lipids in eukaryotic cell membranes. Their tail part is diacylglycerol (DAG), which includes different lengths of saturated or cis-unsaturated fatty acyl chains. Among the mentioned phospholipids, in most eukaryotic membranes, PtdCho constitutes more than 50 percent of phospholipid membrane composition (
18). However, regarding prokaryotic cells, the major structural lipid is phosphatidylglycerol (
17,
20). Surfactin binding to different membranes and its mechanism of action can help us modify and optimize its structure in order to improve the efficacy of this lipopeptide in the future. For this purpose, we studied the interaction of this lipopeptide with two types of lipid bilayer models, including palmitoyl-oleoyl-phosphatidylglycerol (POPG) and 1-palmitoyl-oleoyl-glycero-phosphocholine (POPC) as eukaryotic and prokaryotic membrane models, respectively.